OK, I am looking into the new Midlines by Bard; Power Glides, telling my Critical Care Dr ( my PICC line MD resource) about the midlines and how they are shorter,
but can stay long and have less of the risks versus central lines; like decrease DVT and CRBSI, he says "no they dont", he feels they have the same risk for DVT, and infection.
I do realize the differences in what they can be used for, and I do see a moderate size population that I think they may be appropriate for.
Any studies out there you are aware of that have looked at these issues.?
thanks, Gina
There are no published studies that I am aware of on these new midline catheters such as the PowerGlide. There are several studies with midline catheters inserted with a through the introducer method and from one old device that is no longer on the market. One study of the old catheter found a rate of 0.8 BSI per 1000 catheter days. I can't think of any studies that have studied thrombosis rates in any midline catheter. So I am not sure exactly where your incidence rates are coming from. Lynn
Lynn Hadaway, M.Ed., RN, NPD-BC, CRNI
Lynn Hadaway Associates, Inc.
PO Box 10
Milner, GA 30257
Website http://www.hadawayassociates.com
Office Phone 770-358-7861
I'm looking into midlines as well. I'm looking at the PowerWand. Here is a JAVA article on it. It does give you complication rates.
http://www.accessscientific.com/pdf/Java_17_1_2012.pdf
Frank